SVP - Investor Relations & Corporate Affairs

• Sep 2023 - Present

SVP, Capital Markets & Corporate Communications at Bicycle Therapeutics

• Jan 2023 - Jul 2023

- Led all investor relations, public relations and interactions with 14 covering analysts and their respective bankers, health care hedge funds and long-only investors. Grew number of covering analysts from 9 to 14 - Managed creation of all press releases, clinical data updates, and corporate presentations - Provided regular strategy updates and analysis to executive committee and board of directors - Instrumental in July 2023 $230 million equity raise

VP, Capital Markets & Investor Relations

• Apr 2021 - Jan 2023

- Led overhaul of corporate website, automation of publication review process and inaugural ESG initiative which resulted in Morningstar Sustainaltyics rating of 2 among 436 biotech companies - Key member of team responsible for $201 million equity raise in October 2021

VP, Equity Research Analyst

• Sep 2019 - Apr 2021

- Outperformed benchmarks in management of ~$1.5 billion in Small/Smid-Cap Health Care assets as part of a five-person team with $8 billion in assets - Outperformed benchmarks in management of ~$1.5 billion in Small/Smid-Cap Health Care assets as part of a five-person team with $8 billion in assets

Partner, Equity Analyst

• Sep 2016 - Apr 2019

- Managed, as part of a five-person investment team, assets in the Health Care, Industrial and Energy sectors for $1 billion Micro, Small and Smid-Cap institutional clients - Managed, as part of a five-person investment team, assets in the Health Care, Industrial and Energy sectors for $1 billion Micro, Small and Smid-Cap institutional clients

Director, Co-Portfolio Manager, Senior Research Analyst

• Jan 2015 - Sep 2016

- Co-managed $500 million Small-Cap Growth portfolio which included mutual fund (SSETX) and related accounts. Outperformed benchmark by roughly 200bps during tenure

Director, Senior Research Analyst

• Sep 2013 - Sep 2016

- Managed investments in Health Care and Industrial sectors as part of a five-person team responsible for $2 billion in Small, SMid and Mid-Cap Growth portfolios. Added alpha of 433bps in Small, 452bps in Smid and 11bps in Mid-Cap products during tenure

Equity Analyst, Partner, Associate Portfolio Manager

• Jan 2010 - Aug 2013

- Raised $1 billion of assets and managed $1.4 billion of SMid-Cap Growth assets as part of two-person team

Equity Analyst, Partner

• Oct 2008 - Aug 2013

Was first Equity Analyst to be named Partner.

Equity Analyst

• Jan 2004 - Aug 2013

- Added average annual alpha of 180bps across Small and Smid-Cap products during seven-year period ending 12/31/11 - Total firm AUM increased from $600 million to $2.9 billion during tenure - Gained in-depth knowledge through 80+ annual visits to company headquarters, field offices and trade shows

Industry Analyst

• Jan 2002 - Jan 2004

- Generated consistent record of out-performance in the Health Care and Industrial sectors

Private Equity Principal - Health Care

• Jun 2001 - Jan 2004

- Managed, as part of three person team, hybrid security pool with total assets of $200 million and top-decile performance. - Sourced and closed three health care deals which collectively generated 205% total return and 80% Internal Rate of Return. One company went public, and all three were acquired within four years of initial investment

Small-Cap Growth Research Analyst

• Jul 2000 - Jan 2002

- Provided buy-sell recommendations across all sectors to two portfolio managers responsible for $2 billion.

Client Service Analyst

• Aug 1998 - Jun 2000

- Responsible for maintaining and growing relationships with large institutional investors, both domestic and international. - Responsible for maintaining and growing relationships with large institutional investors, both domestic and international.

Sr Treasury and Investor Relations Analyst

• Jun 1996 - Jul 1998

- Raised $1 billion new debt. Managed share repurchase program. Communicated with institutional investors - Analyzed risk and return of assisting UAM affiliate in conversion of commingled real estate funds to REITs - Raised $1 billion new debt. Managed share repurchase program. Communicated with institutional investors - Analyzed risk and return of assisting UAM affiliate in conversion of commingled real estate funds to REITs